Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug resistance associated with altered DNA topoisomerase II.

Advances in enzyme regulation - 1 Jan 1993

Beck W T, Danks M K, Wolverton J S, Kim R, Chen M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to DNA Topoisomerases, Type II
Share to Drug Resistance
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Genetic

Share to Topoisomerase II Inhibitors

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 8395133
DOI: 10.1016/0065-2571(93)90012-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug resistance associated with altered DNA topoisomerase II.PMID 8395133Read ↗

Drug resistance mechanisms of topoisomerase I drugs.Semantic proximity Read ↗

The role of topoisomerase II alpha and beta in drug resistance.Semantic proximity Read ↗

DNA topoisomerase II mutations and resistance to anti-tumor drugs.Semantic proximity Read ↗

Clinical resistance to topoisomerase-targeted drugsSemantic proximity Read ↗

Mechanisms regulating resistance to inhibitors of topoisomerase IISemantic proximity Read ↗

Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive ReviewSemantic proximity Read ↗

Cracking the Code: Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive ReviewSemantic proximity Read ↗

The cellular origins of drug resistance in cancer.Semantic proximity Read ↗

Genomics and Cancer Drug ResistanceSemantic proximity Read ↗

Understanding the Genetic Mechanisms of Cancer Drug Resistance Using Genomic ApproachesSemantic proximity Read ↗

Involvement of the DNA mismatch repair system in antineoplastic drug resistanceSemantic proximity Read ↗

Mode of action of topoisomerase II-targeting agents at a specific DNA sequenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.